Table 2.

Correlation between distant recurrence and clinicopathological factors, including lectin signals, in patients who underwent curative resection for stage I–III colorectal cancer

Factors	Category	Recurrence (−)	Recurrence (+)	Univariate analysis	Multivariate P-value, relative risk (95% CI)
		(n = 42)	(n = 11)	P-value
Age, mean ± SD (range)		68 ± 13.0 (40–93)	67 ± 16.5 (26–78)	0.249
Sex	Male	20	8	0.138
	Female	22	3
CEA (mean, ng/mL)	<5	29	6	0.140
	≥5	8	5
CA19-9 (mean, U/mL)	<37	32	8	0.598
	≥37	4	2
Ileus	No	37	11	0.296
	Yes	5	0
Adjuvant chemotherapy	No	31	5	0.143
	Yes	11	6
Site	Colon	33	3	0.002	N.S.
	Rectum	9	8
Tumor invasion	pT1/T2	17	1	0.050
	pT3/T4	25	10
Lymph node status	pN0-1	37	6	0.023	N.S.
	pN2-	5	5
Lymphatic invasion	ly−	20	5	0.898
	ly+	22	6
Venous invasion	v−	31	8	0.942
	v+	11	3
Histology	tub1/tub2	39	11	1.000
	por/muc	3	0
pStage	I	17	1	0.122
	II(A+B)	10	3
	III(A+B+C)	15	7
PSA2.367	<2.367	41	10	0.375
	≥2.367	1	1
SNA	<1.956	30	5	0.105
	≥1.956	12	6
SSA	<1.650	29	5	0.136
	≥1.650	13	6
TJA-I	<0.866	10	0	0.075
	≥0.866	32	11
PHA(L)	<0.839	29	4	0.052
	≥0.839	13	7
ECA	<0.781	21	2	0.057
	≥0.781	21	9
RCA120	<1.068	35	8	0.340
	≥1.068	7	3
PHA(E)	<0.664	5	3	0.206
	≥0.644	37	8
NPA	<2.434	39	8	0.096
	≥2.434	3	3
ConA	<1.929	33	7	0.257
	≥1.929	9	4
GNA	<2.053	29	5	0.136
	≥2.053	13	6
HHL	<4.00	41	8	0.025	0.001, 1.69 (1.25–2.28)
	≥4.00	1	3
ACG	<0.951	35	7	0.154
	≥0.951	7	4
BPL	<1.522	41	9	0.106
	≥1.522	1	2
TJA-II	<0.974	36	7	0.112
	≥0.974	6	4
ABA	<2.180	36	4	0.002	0.011, 3.25 (1.31–8.05)
	≥2.180	6	7
PWM	<1.846	31	5	0.079
	≥1.846	11	6
WFA	<0.802	32	8	0.545
	≥0.802	10	3
MPA	<2.456	41	9	0.106
	≥2.456	1	2
VVA	<2.592	41	10	0.375
	≥2.592	1	1
DBA	<0.537	22	4	0.344
	≥0.537	20	7
SBA	<0.997	22	4	0.344
	≥0.997	20	7
Calsepa	<1.541	31	5	0.079
	≥1.541	11	6